Northern Trust’s BioVie BIVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$33.2K Hold
21,820
– – ﹤0.01% 4295
2026
Q2
$42.3K Buy
21,820
+7,631
+54% +$12K ﹤0.01% 4286
2026
Q1
$19.9K Hold
14,189
– – ﹤0.01% 4339
2025
Q4
$16.5K Buy
+14,189
New +$22.8K ﹤0.01% 4407
2025
Q3
– Sell
-2,004
Closed -$18.5K – 4439
2025
Q2
$18.5K Buy
2,004
+474
+31% +$4.68K ﹤0.01% 4339
2025
Q1
$15K Sell
1,530
-158
-9% -$2.53K ﹤0.01% 4368
2024
Q4
$33.8K Buy
+1,688
New +$40.7K ﹤0.01% 4318
2024
Q3
– Sell
-912
Closed -$36.5K – 4418
2024
Q2
$36.5K Sell
912
-243
-21% -$11.6K ﹤0.01% 4260
2024
Q1
$61K Buy
1,155
+66
+6% +$6.77K ﹤0.01% 4190
2023
Q4
$137K Buy
1,089
+679
+166% +$204K ﹤0.01% 4032
2023
Q3
$140K Sell
410
-22
-5% -$8.6K ﹤0.01% 3927
2023
Q2
$186K Buy
432
+231
+115% +$156K ﹤0.01% 3857
2023
Q1
$162K Buy
201
+75
+60% +$49.7K ﹤0.01% 3932
2022
Q4
$98.1K Buy
+126
New +$68.1K ﹤0.01% 4096

Other funds holding BIVI

Northern Trust's BIVI Position: Q3 2026 in Review

Northern Trust held its BioVie (BIVI) position steady in Q3 2026 at 21,820 shares worth $33.2K. The position accounts for ﹤0.01% of the portfolio, ranked #4295.

Northern Trust first reported a position in BIVI in Q4 2022 and has held it in 14 quarters since. The position peaked at $186K in Q2 2023. 32 funds tracked by Wall St. Rank hold BIVI as of Q3 2026.

  • Northern Trust held 21,820 shares of BioVie worth $33.2K as of Q3 2026.
  • Northern Trust left its BioVie share count unchanged in Q3 2026.
  • BioVie made up ﹤0.01% of Northern Trust's portfolio in Q3 2026, its #4295 holding.
  • Northern Trust first reported a position in BioVie in Q4 2022 and has held it in 14 quarters since.
  • Northern Trust's BioVie position peaked at $186K in Q2 2023.
  • 32 funds tracked by Wall St. Rank held BioVie as of Q3 2026.

Based on Northern Trust's 13F filing for Q3 2026, filed 16 Nov 2026.